UK markets closed

Novavax, Inc. (NVAX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
12.99-1.41 (-9.79%)
At close: 04:00PM EDT
13.09 +0.08 (+0.61%)
After hours: 07:59PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
656,665
556,382
1,598,951
197,581
22,388
Cost of revenue
368,891
343,768
902,639
0
0
Gross profit
287,774
212,614
696,312
197,581
22,388
Operating expenses
Research development
583,080
737,502
1,235,278
2,534,508
747,027
Selling general and administrative
443,212
468,946
488,691
298,358
145,290
Total operating expenses
686,348
779,125
1,341,048
1,884,157
439,107
Operating income or loss
-398,574
-566,511
-644,736
-1,686,576
-416,719
Interest expense
14,211
14,416
19,880
21,127
15,145
Total other income/expenses net
17,188
37,896
10,969
-6,833
13,605
Income before tax
-395,597
-543,031
-653,647
-1,714,536
-418,259
Income tax expense
3,110
2,031
4,292
29,215
0
Income from continuing operations
-398,707
-545,062
-657,939
-1,743,751
-418,259
Net income
-398,707
-545,062
-657,939
-1,743,751
-418,259
Net income available to common shareholders
-398,707
-545,062
-657,939
-1,743,751
-418,259
Basic EPS
-6.23
-
-8.42
-23.44
-7.27
Diluted EPS
-6.23
-
-8.42
-23.44
-7.27
Basic average shares
89,744
-
78,183
74,400
57,554
Diluted average shares
89,744
-
78,183
74,400
57,554